Not exact matches
«Existing quality
of life studies have studied older
types of surgery and radiation that are no longer used, and
patients need updated information regarding the impact
of modern treatment options so they can make informed
decisions about the choices they face today.»
«Triple - negative breast cancers tend to be more aggressive compared to other
types of breast cancers, and being able to predict response to therapy could greatly impact treatment
decisions and
patient outcomes,» says study author Shaveta Vinayak, MD, oncologist at UH Case Medical Center and Assistant Professor at Case Western Reserve University School
of Medicine.
Summary: Our goal is to develop a powerful new
type of glaucoma
decision support tool to help eye doctors quickly and effectively identify which glaucoma
patients are at high risk
of getting worse and prevent them from losing more vision.
These are usually personalised to the
patient and are selected based on the
type of breast cancer, the site and extent
of spread as well as the
patient's
decision as to what treatments are acceptable to them.
This
decision will depend on the
type, stage, size, and location
of the cancer, as well as the
patient's overall health, goals, and preferences.
The government may, on its own initiative and without legal compulsion, seek input from
patients with rare diseases in making health care coverage
decisions, and indeed, certain processes have been recently put in place to facilitate public participation in these
types of decisions.
This
type of analysis means relating the additional gains to the additional costs
of an experimental treatment compared with an alternative, such as another treatment or wait list.7 Cost - effectiveness analysis is highly important as it provides information that can be used to guide treatment
decisions, so that more
patients can be treated effectively and waiting times reduced.